Further, the suppression of TU212 cell proliferation and consequent changes in the tumor volume and weight of nude mice after fisetin treatment were connected to decreased Ki67 levels and the inactivation of ERK1/2- and PI3K/AKT-regulated mTOR [124]. The gene discussed is MAPK3; the disease is neoplasm.